Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia: Results From the Phase 2 ADVANCE Study

por Darwish, Mona, Bugarski-Kirola, Dragana, Passarell, Julie, Owen, Joel, Jaworowicz, David, DeKarske, Daryl, Stankovic, Srdjan
Publicado 2022

Retrospective Analysis Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation Offers Improvements in Efficiency of the Design of Volunteer Infection Studies for Antimalarial...

por Andrews, Kayla Ann, Owen, Joel S., McCarthy, James, Wesche, David, Gobeau, Nathalie, Grasela, Thaddeus H., Möhrle, Jörg J.
Publicado 2020

Characterizing plasma albumin concentration changes in TB/HIV patients on anti retroviral and anti –tuberculosis therapy

por Bisaso, Kuteesa R, Owen, Joel S, Ojara, Francis W, Namuwenge, Proscovia M, Mugisha, Apollo, Mbuagbaw, Lawrence, Luboobi, Livingstone S, Mukonzo, Jackson K
Publicado 2014

Erratum to: Characterizing plasma albumin concentration changes in TB/HIV patients on anti retroviral and anti –tuberculosis therapy

por Bisaso, Kuteesa R, Owen, Joel S, Ojara, Francis W, Namuwenge, Proscovia M, Mugisha, Apollo, Mbuagbaw, Lawrence, Luboobi, Livingstone S, Mukonzo, Jackson K
Publicado 2015

Pharmacogenetic-Based Efavirenz Dose Modification: Suggestions for an African Population and the Different CYP2B6 Genotypes

por Mukonzo, Jackson K., Owen, Joel S., Ogwal-Okeng, Jasper, Kuteesa, Ronald B., Nanzigu, Sarah, Sewankambo, Nelson, Thabane, Lehana, Gustafsson, Lars L., Ross, Colin, Aklillu, Eleni
Publicado 2014